Akada, J. K., Shirai, M., Fujii, K., Okita, K., & Nakazawa, T. (1999). In Vitro Anti-Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657. American Society for Microbiology.
Chicago Style CitationAkada, Junko K., Mutsunori Shirai, Kenji Fujii, Kiwamu Okita, i Teruko Nakazawa. In Vitro Anti-Helicobacter Pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657. American Society for Microbiology, 1999.
Cita MLAAkada, Junko K., et al. In Vitro Anti-Helicobacter Pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657. American Society for Microbiology, 1999.
Atenció: Aquestes cites poden no estar 100% correctes.